These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38309119)

  • 41. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical application of
    Nakajo M; Jinguji M; Ito S; Tani A; Hirahara M; Yoshiura T
    Jpn J Radiol; 2024 Jan; 42(1):28-55. PubMed ID: 37526865
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Salomäki SP; Saraste A; Kemppainen J; Hurme S; Knuuti J; Nuutila P; Seppänen M; Roivainen A; Airaksinen J; Salo T; Oksi J; Pirilä L; Hohenthal U
    J Nucl Cardiol; 2021 Dec; 28(6):2992-3003. PubMed ID: 32737839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
    Verghote F; Poppe L; Verbeke S; Dirix P; Albersen M; De Meerleer G; Berghen C; Ost P; Villeirs G; De Visschere P; De Man K; De Maeseneer D; Rottey S; Van Praet C; Decaestecker K; Fonteyne V
    BMC Cancer; 2021 Oct; 21(1):1113. PubMed ID: 34663254
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Grobman M; Cohn L; Knapp S; Bryan JN; Reinero C
    Vet Radiol Ultrasound; 2018 Jan; 59(1):107-115. PubMed ID: 28925085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.
    Park S; Lee HY; Lee S
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):215-224. PubMed ID: 34106327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incremental Value of 18 F-FDG-Labeled Leukocytes PET/CT Over 18 F-FDG PET/CT Scan in the Detection of Occult Infection.
    Manda D; Thakral P; Sen I; Das SS; Cb V; Malik D
    Clin Nucl Med; 2022 Sep; 47(9):e574-e581. PubMed ID: 35776834
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Bouter C; Braune I; Meller B; Sahlmann C; Ritter C; Meller J
    Nuklearmedizin; 2016 Dec; 55(6):242-249. PubMed ID: 27617327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
    Öztürk H
    Cancer Res Treat; 2015 Oct; 47(4):834-43. PubMed ID: 25687863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hybrid PET- and MR-driven attenuation correction for enhanced
    Karakatsanis NA; Abgral R; Trivieri MG; Dweck MR; Robson PM; Calcagno C; Boeykens G; Senders ML; Mulder WJM; Tsoumpas C; Fayad ZA
    J Nucl Cardiol; 2020 Aug; 27(4):1126-1141. PubMed ID: 31667675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High (18)F-FDG uptake in urinary calculi on PET/CT: An unrecognized non-malignant accumulation.
    Fu Z; Li Z; Huang J; Zhang J; Liu M; Li Q; Li Y
    Eur J Radiol; 2016 Aug; 85(8):1395-9. PubMed ID: 27423678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of biological parameters in head and neck cancer based on in vivo distribution of
    Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W
    Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
    Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
    AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
    [No Abstract]   [Full Text] [Related]  

  • 55. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG.
    Pencharz D; McMeekin H; Wagner T; Wickham F
    Nucl Med Commun; 2016 Aug; 37(8):860-4. PubMed ID: 27115065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Clinical Impact of Using
    Taimen K; Salomäki SP; Hohenthal U; Mali M; Kajander S; Seppänen M; Nuutila P; Palomäki A; Roivainen A; Pirilä L; Kemppainen J
    Contrast Media Mol Imaging; 2019; 2019():9157637. PubMed ID: 31531005
    [No Abstract]   [Full Text] [Related]  

  • 58. Subtype-Guided
    Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
    Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of
    Albano D; Zizioli V; Treglia G; Odicino F; Giubbini R; Bertagna F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):10-16. PubMed ID: 30396849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.